Regional cerebral blood flow after recovery from bulimia nervosa.

Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70

Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry (2001) 2.70

PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry (1999) 2.48

Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. J Nucl Med (2000) 2.33

Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med (1999) 2.30

Hyperamylasemia and its relationship to binge-purge episodes: development of a clinically relevant laboratory test. J Clin Psychiatry (1989) 2.30

Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry (2003) 2.12

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.89

A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch Gen Psychiatry (1998) 1.76

The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Virology (1986) 1.76

Imaging recommendations for acute stroke and transient ischemic attack patients: A joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery. AJNR Am J Neuroradiol (2013) 1.71

Persistent perfectionism, symmetry, and exactness after long-term recovery from anorexia nervosa. Am J Psychiatry (1995) 1.61

Spinal accessory nerve preservation during neck dissection. Laryngoscope (1991) 1.50

Short-term neuroendocrine effects of a large oral dose of monosodium glutamate in fasting male subjects. J Clin Endocrinol Metab (1996) 1.49

Abnormal caloric requirements for weight maintenance in patients with anorexia and bulimia nervosa. Am J Psychiatry (1991) 1.46

Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg (1999) 1.42

Brain tumor volume measurement: comparison of manual and semiautomated methods. Radiology (1999) 1.42

Obsessive-compulsive disorder symptoms before and after recovery from bulimia nervosa. Am J Psychiatry (1999) 1.42

Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat Neurosci (2006) 1.40

Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology (2005) 1.39

Fungal spinal osteomyelitis in the immunocompromised patient: MR findings in three cases. AJNR Am J Neuroradiol (1999) 1.38

Characterization of elk, a brain-specific receptor tyrosine kinase. Mol Cell Biol (1991) 1.34

Relationship of depression, anxiety, and obsessionality to state of illness in anorexia nervosa. Int J Eat Disord (1997) 1.31

Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging. AJNR Am J Neuroradiol (2009) 1.29

The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene (1993) 1.27

Perfectionism in anorexia nervosa: variation by clinical subtype, obsessionality, and pathological eating behavior. Am J Psychiatry (2000) 1.27

Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene. In Vitro Cell Dev Biol Anim (1996) 1.23

Cerebral responses to noxious thermal stimulation in chronic low back pain patients and normal controls. Neuroimage (2002) 1.23

Quantification of neuroreceptors in the living human brain: III. D2-like dopamine receptors: theory, validation, and changes during normal aging. J Cereb Blood Flow Metab (1997) 1.19

Complications and early outcome of anterior craniofacial resection. Arch Otolaryngol Head Neck Surg (1992) 1.18

Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. Am J Hum Genet (2002) 1.17

A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry (2000) 1.16

Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med (2000) 1.15

Low discharge weight and outcome in anorexia nervosa. Am J Psychiatry (1995) 1.13

Temperament and character in women with anorexia nervosa. J Nerv Ment Dis (2000) 1.11

Perfectionism in anorexia nervosa. Int J Eat Disord (1995) 1.11

Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres. J Microencapsul (1997) 1.11

Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab (2001) 1.10

Cerebral blood flow in hypertensive patients: an initial report of reduced and compensatory blood flow responses during performance of two cognitive tasks. Hypertension (1998) 1.10

Fluorine-18-fluorodeoxyglucose uptake in pneumonia. J Nucl Med (1998) 1.10

Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol (2002) 1.09

Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry (2001) 1.09

Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am J Psychiatry (1999) 1.08

Modest facilitation on memory in dementia with combined lecithin and anticholinerestase treatment. Biol Psychiatry (1982) 1.08

Gender-specific aging effects on the serotonin 1A receptor. Brain Res (2001) 1.08

Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors. Eur J Pharm Biopharm (2001) 1.08

Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol (1992) 1.08

A positron emission tomography (PET) study of autobiographical memory retrieval. Memory (2000) 1.07

Functional neuroanatomy of semantic memory: recognition of semantic associations. Neuroimage (1999) 1.06

The fps/fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells and is localized in the trans-golgi network. Cell Growth Differ (1996) 1.06

Disruption of coiled-coil domains in Fer protein-tyrosine kinase abolishes trimerization but not kinase activation. J Biol Chem (1999) 1.06

Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry (1992) 1.05

Twenty-four-hour food intake in patients with anorexia nervosa and in healthy control subjects. Biol Psychiatry (1994) 1.04

PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Neuropsychopharmacology (1999) 1.02

Premorbid onset of psychopathology in long-term recovered anorexia nervosa. Int J Eat Disord (1995) 1.02

Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET. Am J Physiol (1999) 1.01

Serotonin type-1A receptor imaging in depression. Nucl Med Biol (2000) 1.01

Acceleration of cerebral ventricular expansion in the Cardiovascular Health Study. Neurobiol Aging (2006) 1.01

Personality traits among currently eating disordered, recovered and never ill first-degree female relatives of bulimic and control women. Psychol Med (2000) 1.01

Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope (1980) 1.00

MR imaging response of brain metastases after gamma knife stereotactic radiosurgery. Radiology (1999) 0.99

Cerebral MR imaging in intravascular lymphomatosis. AJNR Am J Neuroradiol (1998) 0.99

Development and characterization of buoyant theophylline microspheres with near zero order release kinetics. J Microencapsul (1999) 0.99

Life-threatening hemorrhage from a Le Fort I osteotomy. J Oral Maxillofac Surg (1982) 0.98

Psychiatric disorders in women with bulimia nervosa and their first-degree relatives: effects of comorbid substance dependence. Int J Eat Disord (1997) 0.98

Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies. Pharm Res (1994) 0.98

MR imaging of the meninges. Part II. Neoplastic disease. Radiology (1996) 0.97

Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Eur J Pharm Biopharm (2005) 0.97

Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. Am J Psychiatry (2001) 0.97

Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Mol Psychiatry (2003) 0.97

Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab (1997) 0.97

Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography. Diabetes (2001) 0.95

Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry (1984) 0.95

Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg (1997) 0.95

Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology (2005) 0.94

Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Synapse (1998) 0.94

Altered norepinephrine regulation in bulimia: effects of pharmacological challenge with isoproterenol. Psychiatry Res (1990) 0.94

A method for the assessment of the functional neuroanatomy of human sleep using FDG PET. Brain Res Brain Res Protoc (1998) 0.94

Formulation, preparation and dissolution characteristics of propranolol hydrochloride microspheres. J Microencapsul (1994) 0.93

Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method. J Microencapsul (2003) 0.93

Temperament in eating disorders. Int J Eat Disord (1995) 0.93

Slowing of pulsatile luteinizing hormone secretion in men after forty-eight hours of fasting. J Clin Endocrinol Metab (1991) 0.93

5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet (1998) 0.93

Towards a neurobiology of dysfunctional arousal in depression: the relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep. Psychiatry Res (2000) 0.93

3-D CT for cranial facial and laryngeal surgery. Laryngoscope (1988) 0.92

Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocrinol Metab (1987) 0.92

Investigation of a methicillin-resistant Staphylococcus aureus (MRSA) outbreak in an Irish hospital: triplex PCR and DNA amplification fingerprinting. J Hosp Infect (1997) 0.92

Hyperostotic esthesioneuroblastoma: CT and MR findings. J Comput Assist Tomogr (1988) 0.92

Epidemic Legionnaires' disease two decades later: old sources, new diagnostic methods. Clin Infect Dis (1998) 0.92

Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res (1998) 0.92

PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry (1999) 0.91